-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Insight Molecular, Maintains $9 Price Target

Benzinga·08/18/2026 10:30:22
Listen to the news
Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $9 price target.